Cited by 84Vestibular and auditory disordersHearing, Cochlea, Tinnitus, GeneticsAcute Ischemic Stroke Management

Recovery of idiopathic sudden sensorineural hearing loss

Open access
Edizer, Deniz Tuna, Çelebi, Özlem, Hamit, Bahtiyar, Baki, Ahmet, Yiğit, Özgür·2019·The Journal of International Advanced Otology

Abstract

Objective The objective was to identify and evaluate factors that may influence the recovery rate in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Materials and methods A retrospective analysis was performed for patients with sudden sensorineural hearing loss between 2009 and 2013. Those with an identified etiology were excluded. The patients were divided into four treatment groups: (i) systemic corticosteroids (SC) only, (ii) SC+low-molecular-weight heparin (LMWH), (iii) SC+hyperbaric oxygen (HBO), and (iv) SC+LMWH+HBO. Recovery was evaluated according to Siegel's criteria. Age, initial hearing level, onset, treatment and audiogram types, comorbidities, and associated tinnitus and vestibular symptoms were investigated for their impact on prognosis. Results Two hundred five patients with ISSNHL were included. Recovery was seen in 59% of the patients. The complete recovery rate was significantly lower in patients older than 60 years and in patients presenting with profound hearing loss. Different audiogram curves had no significant effect on recovery. Sudden hearing loss was accompanied by tinnitus in 107 (52.1%) patients and vestibular symptoms in 55 (26.8%); however, neither was noted to affect prognosis. Different treatment combinations did not significantly affect prognosis. However, hypertension and a delay in treatment by more than 10 days from the onset of hearing loss were associated with a worse prognosis. Conclusion Profound hearing loss, older…

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5152/iao.2015.1227

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. [1]1. Psifidis AD, Psillas GK, Daniilidis JCh. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg 2006; 134: 809-15. [CrossRef]
  2. [2]2. Chao TK, Chen TH. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss. Audiol Neurootol 2006; 11: 331-8. [CrossRef]
  3. [3]3. Penido Nde O, Ramos HV, Barros FA, Cruz OL, Toledo RN. Clinical, etiological and progression factors of hearing in sudden deafness. Braz J Otorhinolaryngol 2005; 71: 633-8.
  4. [4]4. Sano H, Okamoto M, Ohhashi K, Iwasaki S, Ogawa K. Quality of life reported by patients with idiopathic sudden sensorineural hearing loss. Otol Neurotol 2013; 34: 36-40. [CrossRef]
  5. [5]5. Borton SA, Mauze E, Lieu JE. Quality of life in children with unilateral hearing loss: a pilot study. Am J Audiol 2010; 19: 61-72. [CrossRef]
  6. [6]6. Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008; 359: 833-40. [CrossRef]
  7. [7]7. Enache R, Sarafoleanu C. Prognostic factors in sudden hearing loss. J Med Life 2008; 1: 343-7.
  8. [8]8. Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000; 126: 1161-4. [CrossRef]
  9. [9]9. Kaya H, Koç AK, Sayın İ, Güneş S, Altıntaş A, Yeğin Y, et al. Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2015; 272: 1119-25. [CrossRef]
  10. [10]10. Wen YH, Chen PR, Wu HP. Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2014; 271: 1423-9. [CrossRef]
  11. [11]11. Süslü N, Yilmaz T, Gürsel B. Utility of anti-HSP 70, TNF-alpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Laryngoscope 2009; 119: 341-6. [CrossRef]
  12. [12]12. Park KH, Lee CK, Lee JD, Park MK, Lee BD. Combination therapy with systemic steroids, an antiviral agent, anticoagulants, and stellate ganglion block for treatment of sudden sensorineural hearing loss. Korean J Audiol 2012; 16: 71-4. [CrossRef]
  13. [13]13. Yang CH, Wu RW, Hwang CF. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Otol Neurotol 2013; 34: 1411-6. [CrossRef]
  14. [14]14. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146: S1-35. [CrossRef]
  15. [15]15. Lee HS, Lee YJ, Kang BS, Lee BD, Lee JS. A clinical analysis of sudden sensorineural hearing loss cases. Korean J Audiol 2014; 18: 69-75. [CrossRef]
  16. [16]16. Ceylan A, Celenk F, Kemaloğlu YK, Bayazit YA, Göksu N, Ozbilen S. Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol 2007; 121: 1035-40. [CrossRef]
  17. [17]17. Chang NC, Ho KY, Kuo WR. Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolaryngol Head Neck Surg 2005; 133: 916-22. [CrossRef]
  18. [18]18. Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg 2003; 128: 92-8. [CrossRef]
  19. [19]19. Mamak A, Yilmaz S, Cansiz H, Inci E, Güçlü E, Dereköylü L. A study of prognostic factors in sudden hearing loss. Ear Nose Throat J 2005; 84: 641-4.
  20. [20]20. Cvorović L, Deric D, Probst R, Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008; 29: 464-9. [CrossRef]
  21. [21]21. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol 2012; 33: 523-31. [CrossRef]
  22. [22]22. Wang CT, Huang TW, Kuo SW, Cheng PW. Correlation between audiovestibular function tests and hearing outcomes in severe to profound sudden sensorineural hearing loss. Ear Hear 2009; 30: 110-4. [CrossRef]
  23. [23]23. Cho CS, Choi YJ. Prognostic factors in sudden sensorineural hearing loss: a retrospective study using interaction effects. Braz J Otorhinolaryngol 2013; 79: 466-70. [CrossRef]
  24. [24]24. Tiong TS. Prognostic indicators of management of sudden sensorineural hearing loss in an Asian hospital. Singapore Med J 2007; 48: 45-9.
  25. [25]25. Wen YH, Chen PR, Wu HP. Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2014; 271: 1423-9. [CrossRef]
  26. [26]26. Xenellis J, Karapatsas I, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Tzagkaroulakis M, Ferekidis E. Idiopathic sudden sensorineural hearing loss: prognostic factors. J Laryngol Otol 2006; 120: 718-24. [CrossRef]
  27. [27]27. Ben-David J, Luntz M, Magamsa I, Fradis M, Sabo E, Podoshin L. Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss. Int Tinnitus J 2001; 7: 62-4.
  28. [28]28. Weng SF, Chen YS, Hsu CJ, Tseng FY. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005; 115: 1676-80. [CrossRef]
  29. [29]29. Ulrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992; 249: 273-6. [CrossRef]
  30. [30]30. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 2007; 133: 573-81. [CrossRef]
  31. [31]31. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 2007; 133: 582-6. [CrossRef]
  32. [32]32. Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2007; 264: 861-6. [CrossRef]
  33. [33]33. Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011; 268: 1735-41. [CrossRef]
  34. [34]34. Satar B, Hidir Y , Yetiser S. Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss. J Laryngol Otol 2006; 120: 665-9. [CrossRef]

Cited by

Sorted by citations

Authors
Edizer, D. T., Çelebi, Ö., Hamit, B., Baki, A., & Yiğit, Ö.
Venue
The Journal of International Advanced Otology
Publisher
Caleo
Published
2019-09-03
Volume
11
Issue
2
Pages
122-126
ISSN
  • 1308-7649 (ISSN-L)
  • 2148-3817
OpenAlex
W2413006837
Cited by
84
References
0
Citations by year
2026: 3 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 12 · 2020: 15 · 2019: 9 · 2018: 6 · 2017: 3 · 2016: 4
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • The Journal of International Advanced Otology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
Keywords
idiopathic sudden sensorineural hearing loss, hearing recovery, prognostic factors, systemic corticosteroids, low molecular weight heparin, hyperbaric oxygen therapy, tinnitus, vestibular symptoms, hypertension, treatment delay, age, profound hearing loss
MeSH terms
Adult, Audiometry, Pure-Tone, Combined Modality Therapy, Hearing Loss, Sudden, Female, Glucocorticoids, Hearing Loss, Sensorineural, Heparin, Low-Molecular-Weight, Humans, Hyperbaric Oxygenation, Hypertension, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Turkey, Comorbidity, Treatment Outcome, Recovery of Function, Time-to-Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review